Form 8-K - Current report:
SEC Accession No. 0001193125-21-124776
Filing Date
2021-04-21
Accepted
2021-04-21 16:28:32
Documents
12
Period of Report
2021-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d170447d8k.htm   iXBRL 8-K 23221
  Complete submission text file 0001193125-21-124776.txt   145405

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210416.xsd EX-101.SCH 3103
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210416_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210416_pre.xml EX-101.PRE 11430
5 EXTRACTED XBRL INSTANCE DOCUMENT d170447d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21841850
SIC: 2834 Pharmaceutical Preparations